Search Within

Renier J Brentjens

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (8)
  3. Review (1)
Groups
  1. Adult Leukemia (21)
  2. Center for Hematologic Malignancies (21)
  3. Center for Molecular Imaging and Biotechnology (21)
  4. Department of Medicine (21)
  5. GSK Faculty (21)
  6. Hematologic Malignancies Research (21)

More Groups

People
  1. David Scheinberg (12)
  2. Nancy Kernan (8)
  3. Richard O'Reilly (8)
  4. Kevin Curran (7)
  5. Isabelle Riviere (6)
  6. Joseph Jurcic (6)

More People

Years
  1. 2022 (1)
  2. 2020 (4)
  3. 2019 (2)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (2)

More Years

Publications
  1. Blood (8)
  2. Bone Marrow Transplantation (2)
  3. Journal of Clinical Oncology (2)
  4. Molecular Therapy (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Nature Publishing Group (5)
  3. American Association for Cancer Research (2)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Inc. (1)
  6. MDPI (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chimeric antigen receptor T cells for cancer immunotherapy
    Meeting Abstract

    Curran, K. J.; Silverman, L. B.; Kobos, R.; Kernan, N. A.; Margossian, S. P.; Park, J. H.; Sauter, C. S.; Szenes, V.; Wang, X. Y.; O'Reilly, R. J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
    Journal Article

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S. M.; Lubin, M.; Giralt, S.; Goldberg, J. D.; Hanash, A.; Hsu, K.; Jenq, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Engineered T cell receptor-mimic antibody, (TCRm) chimeric antigen receptor (CAR) T cells against the intracellular protein Wilms tumor-1 (WT1) for treatment of hematologic and solid cancers
    Meeting Abstract

    Rafiq, S.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells targeting the CD19 antigen for the treatment of pediatric relapsed B cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Kobos, R.; Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Renaud, T. M.; Shukla, N.; Steinherz, P. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Aerobic glycolysis predicts outcome in early chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S.; Knapp, K.; Bauli, F.; Lamanna, N.; Frattini, M. G.; Brentjens, R. J.; Maslak, P. G.; Jurcic, J. G.; Weiss, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • CD19 targeted allogeneic EBV-specific T cells for the treatment of relapsed ALL in pediatric patients post HSCT
    Meeting Abstract

    Curran, K. J.; Kernan, N. A.; Wang, X. Y.; Taylor, C.; Doubrovina, E.; Bartido, S.; Sadelain, M.; O'Reilly, R. J.; Brentjens, R. J.; Riviere, I.
    Blood (2012)

    Fulltext@MSK | Save
  • Elevated mitochondrial membrane potential in CLL cells is associated with a more aggressive natural history
    Meeting Abstract

    Gardner, J. R.; Knapp, K.; Frattini, M. G.; Lamanna, N.; Brentjens, R.; Jurcic, J. G.; Maslak, P. G.; Berman, E.; Weiss, M.; Scheinberg, D. A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes
    Journal Article

    McDevitt, M. R.; Chattopadhyay, D.; Kappel, B. J.; Jaggi, J. S.; Schiffman, S. R.; Antczak, C.; Njardarson, J. T.; Brentjens, R.; Scheinberg, D. A.
    Journal of Nuclear Medicine (2007)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save